Scynexis (SCYX) EBITDA Margin Growth (5y) (2018 - 2024)
Scynexis (SCYX) EBITDA Margin Growth (5y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | -2.72 Mn |
| Sep 30, 2023 | 927,345.00 |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | -1.81 Mn |
| Sep 30, 2022 | 859,824.00 |
| Jun 30, 2022 | 889,598.00 |
| Mar 31, 2022 | 658,029.00 |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 671,049.00 |
| Mar 31, 2021 | 1.13 Mn |
| Jun 30, 2019 | -1.35 Mn |
| Mar 31, 2019 | -1.85 Mn |
| Dec 31, 2018 | 2.68 Mn |
| Sep 30, 2018 | -979,854.00 |
| Jun 30, 2018 | -1.19 Mn |
| Mar 31, 2018 | -1.13 Mn |